Archives for April 5, 2006

← 2006

UK regulator's suitability to investigate Parexel questioned

By  Gregory Roumeliotis

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has said it has so far found no evidence of wrongdoing in the human trials of the monoclonal antibody TGN1412, which US contract research firm Parexel carried out for German TeGenero,...

Biotech industry close to net profit

By  Gregory Roumeliotis

For the first time in its 30-year history, the biotechnology industry in 2005 surpassed $60bn (€49bn) in revenues according to Ernst & Young's 2006 Global Biotechnology Report, an astounding growth considering that in 1996 industry revenues amounted...

Achieving success in IT outsourcing

By Kirsty Barnes

To increase the chance of success in IT outsourcing, companies must increase their focus on creating and managing a successful mixture of supplier relationships that work for them.

Eden's cGMP services recruited into Onyvax's cancer program

By  Wai Lang Chu

Eden Biodesign and Onyvax have announced the formation of a unique biomanufacturing contract, in which the Onyvax's development of novel cancer therapies will be supported by Eden's cGMP clinical manufacturing services.

Wyatt releases powerful light scattering detector

By  Wai Lang Chu

Wyatt Technology launches its newest addition to its Multi-Angle Light Scattering (MALS) Detector range, boasting twice the signal to noise ratio and 100x the dynamic range of previous Wyatt's miniDAWN instruments.